Table 2—

Cumulative incidence of diabetes for those who were NGT/IGT at baseline

Women
Men
Case subjectsnIncidenceInc. ratio95% CICase subjectsnIncidenceInc. ratio95% CI
NGT
 Obesity status (BMI)
  Normal, BMI <2571325.3%1.061264.8%1.0
  Overweight2620013.0%2.51.1–5.5182417.5%1.60.64–3.85
  Obese, BMI ≥304525317.8%3.41.6–7.22617914.5%3.11.29–7.19
  P value0.0030.007
 Waist-to-hip ratio
  Low, <0.89 (women), 0.93 (men)151957.7%1.081784.5%1.0
  Medium3019415.5%2.01.12–3.62181849.8%2.20.97–4.88
  High, ≥ 0.95 (women), 0.98 (men)3319417.0%2.21.24–3.942417713.6%3.01.39–6.53
  P value0.0150.012
 Fasting glucose
  Low, <96 (women), 97 (men)191939.8%1.0121856.5%1.0
  Medium2219911.1%1.10.63–2.01141837.7%1.20.56–2.48
  High, ≥105 (women), 106 (men)3719319.2%1.91.16–3.262417913.4%2.11.07–4.01
  P value0.0130.050
 Insulin
  Low, <8.89 (women), 7.32 (men)111955.6%1.041822.2%1.0
  Medium2619513.3%2.41.20–4.652018211.0%5.01.74–14.34
  High, ≥ 14.97 (women), 14.18 (men)4119521.0%3.71.97–7.042618214.3%6.52.31–18.25
  P value<0.001<0.001
 Albuminuria
  Absence (normal)6653012.5%1.0425008.4%1.0
  Presence (micro + macro)125422.2%1.81.03–3.0984318.6%2.21.11–4.41
  P value0.0440.026
IGT
 Degree of Indian blood
  not full blooded, < 100%3011526.1%1.0135225.0%1.0
  full blooded, 100%10224641.5%1.61.13–2.245311944.5%1.81.07–2.97
  P value0.0050.016
 2-h glucose
  Low, <153 (women), 151 (men)3212326.0%1.0105817.2%1.0
  Medium4411837.3%1.40.98–2.09255644.6%2.61.37–4.89
  High, ≥ 171 (women), 169 (men)5612046.7%1.81.26–2.56315754.4%3.21.71–5.82
  P value0.004<0.001
 Insulin
  Low, <12.32 (women), 13.3 (men)3512029.2%1.0135722.8%1.0
  Medium3812131.4%1.10.73–1.58245742.1%1.81.05–3.25
  High, ≥20.73 (women), 22.18 (men)5912049.2%1.71.21–2.35295750.9%2.21.30–3.83
  P value0.0020.007
 HbA1c
  Low, <5.1 (women), 5.2 (men)3312027.5%1.0185930.5%1.0
  Medium349834.7%1.30.85–1.88165032.0%1.00.60–1.83
  High, ≥5.5 (women), 5.6 (men)5812147.9%1.71.23–2.46295651.8%1.71.07–2.69
  P value0.0040.035
  • P values from χ2 tests.